Learn about the global Vaccines market through The Business Research Company, which provides information on vaccines market size, vaccines market drivers and restraints, vaccines market players, the COVID-19 impact on the vaccines market, and more.

The global vaccines market size is expected to decline from $92.70 billion in 2021 to $105.20 billion in 2022 at a compound annual growth rate (CAGR) of 13.5%. The slow decline is mainly due to the outbreak of COVID-19 that has led to deferment of immunocompromised treatments. The vaccine market is expected to reach $290.67 billion in 2026 at a CAGR of 28.9%.

Rising awareness on immunization and vaccination benefits in emerging markets is consistently driving the global vaccines market growth.

Request A Sample For The Global Vaccines Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2556&type=smp

The vaccines market consists of sales of vaccines and related services. This industry includes establishments that produce anti-infective vaccines, autoimmunity vaccines and vaccines for cancer and other diseases. Vaccines create antibody-antigen reaction that helps in attaining resistance to the disease causing organism. Vaccines include recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated vaccines, toxoid vaccines and others.

Global Vaccines Market Segments Include:

By Type: Anti-Infective Vaccines, Autoimmunity, Others (Cancer and Others)

By Technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines

By Route of Administration: Intramuscular (IM), Subcutaneous (SC), Oral, Others

By Valence: Monovalent, Multivalent

By Distribution Channel: Institutional Sale, Hospital Pharmacies, Retail Pharmacies

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the vaccine market in 2021.

The vaccines market has been witnessing multiple strategic initiatives and mergers and acquisitions in the recent years. Top companies in the market are strategically acquiring start-ups and mid-sized companies to broaden products and services.

TBRC’s vaccines market report covers:

Major Market Players: AstraZeneca, Emergent Biosolutions, Glaxosmithkline, Merck, Pfizer, Sanofi Pasteur, Abbott, Astellas Pharma, Bavarian Nordic, CSL Limited, Daiichi Sankyo Company, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India, Takeda Pharmaceutical Co. Ltd., Biological E Limited, BiondVax Pharmaceuticals Ltd, Bristol-Myers Squibb, Inovio Pharmaceuticals Inc., Madison Vaccines Incorporated, NOVARTIS AG, Novavax Inc., Panacea Biotec, Sinovac Biotech Ltd., Valneva SE, and VBI Vaccine Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Vaccines Global Market Report 2022– Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides vaccines market overviews, analyses and forecasts market size, share, vaccines market players, vaccines market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s vaccines market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Cancer Vaccines Global Market Report 2021

DTP Vaccines Global Market Report 2021

Companion Animal Veterinary Vaccines Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: